BIRC6 and breast cancer: In this study, a decrease in cell viability induced by BIRC6 reduction did not confine to cells expressing wild-type p53, contrary to previous reports suggesting that apoptosis resulting from BIRC6 knockdown in H460 cells and breast cancer cells requires functional p53 [23], [25].